Treatment with Vinpocetine in the Diabetes and Vinpocetine group led to a significant reduction in TGF-Beta levels compared to both the Diabetes and saline treatment group and the Normal Control group (p < 0.001) (Table 2). Here, TGFB1 is linked to diabetes mellitus.